Cargando…
Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation
The major clinical problem in human cancer is metastasis. Metastases are the cause of 90% of human cancer deaths. TAp63 is a critical suppressor of tumorigenesis and metastasis. ΔNp63 acts as a dominant-negative inhibitor to block the function of p53 and TAp63. Although several ubiquitin E3 ligases...
Autores principales: | Wu, H Helena, Wang, Benfan, Armstrong, Stephen R, Abuetabh, Yasser, Leng, Sarah, Roa, Wilson H Y, Atfi, Azeddine, Marchese, Adriano, Wilson, Beverly, Sergi, Consolato, Flores, Elsa R, Eisenstat, David D, Leng, Roger P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969027/ https://www.ncbi.nlm.nih.gov/pubmed/33619536 http://dx.doi.org/10.1093/nar/gkab081 |
Ejemplares similares
-
The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System
por: Armstrong, Stephen R., et al.
Publicado: (2016) -
p63, a key regulator of Ago2, links to the microRNA-144 cluster
por: Wang, Benfan, et al.
Publicado: (2022) -
ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019) -
DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma
por: Pokorna, Zuzana, et al.
Publicado: (2022) -
Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019)